SC 13D
SC 13D Filing
- Company
- Bone Biologics Corp
- Filed
- July 25, 2018
- Accession Number
- 0001493152-18-010434
A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →